Published in Kidney Int Suppl on August 01, 2007
A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol (2011) 2.51
Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol (2012) 1.42
Rationally designed peptide regulators of protein kinase C. Trends Endocrinol Metab (2008) 1.17
PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemia. J Biol Chem (2011) 1.17
Inadequate diabetic care: global figures cry for preventive measures and personalized treatment. EPMA J (2010) 1.10
Aldose reductase, oxidative stress, and diabetic mellitus. Front Pharmacol (2012) 1.10
Autophagy in diabetic nephropathy. J Endocrinol (2014) 1.06
Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis (2014) 1.01
Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals. Mediators Inflamm (2014) 0.93
Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathy. Lab Invest (2010) 0.88
Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders. Eur J Nutr (2016) 0.82
Restoration of Na+/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid loss. J Clin Invest (2015) 0.81
Neuroprotective effect of resveratrol in diabetic cerebral ischemic-reperfused rats through regulation of inflammatory and apoptotic events. Diabetol Metab Syndr (2014) 0.79
Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice. Diabetologia (2011) 0.79
Tandem inhibition of PKC in Diαβetic nephropathy: it takes two to tango? Diabetes (2013) 0.78
Podocyte directed therapy of nephrotic syndrome-can we bring the inside out? Pediatr Nephrol (2015) 0.78
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets. J Diabetes Res (2015) 0.77
Dietary avocado oil supplementation attenuates the alterations induced by type I diabetes and oxidative stress in electron transfer at the complex II-complex III segment of the electron transport chain in rat kidney mitochondria. J Bioenerg Biomembr (2013) 0.76
DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats. Diabetol Metab Syndr (2015) 0.76
Protein kinase C-β gene variants and type 2 diabetes-associated kidney failure: What can we learn from gene association studies in diabetic nephropathy? Am J Kidney Dis (2010) 0.75
Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats. Am J Physiol Heart Circ Physiol (2015) 0.75
Breviscapine attenuatted contrast medium-induced nephropathy via PKC/Akt/MAPK signalling in diabetic mice. Am J Transl Res (2016) 0.75
Antidiabetic and renoprotective effects of Cladophora glomerata Kützing extract in experimental type 2 diabetic rats: a potential nutraceutical product for diabetic nephropathy. J Diabetes Res (2015) 0.75
ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy. KI Rep (2016) 0.75
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A (1995) 5.92
Diabetic retinopathy. Diabetes Care (1998) 3.39
Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation (1999) 3.35
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest (1999) 3.18
Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes (1997) 3.08
Protein kinase C activation and the development of diabetic complications. Diabetes (1998) 2.93
Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science (1996) 2.80
Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A (1992) 2.48
Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A (1989) 2.45
Receptor-mediated transport of insulin across endothelial cells. Science (1985) 2.42
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest (1996) 2.36
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes (1999) 2.21
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. Circulation (2000) 2.18
Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor. J Clin Invest (1980) 2.15
Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A (1997) 2.02
Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest (1985) 2.00
Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J (2000) 1.93
Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J Physiol (1986) 1.83
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care (1999) 1.78
Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes (1994) 1.75
Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest (1997) 1.75
Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest (1999) 1.72
Insulin receptors, receptor antibodies, and the mechanism of insulin action. Recent Prog Horm Res (1981) 1.68
Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci (2000) 1.67
Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem (2000) 1.67
Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes (1993) 1.60
A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J Exp Med (1988) 1.55
Protein kinase C and the development of diabetic vascular complications. Diabet Med (2001) 1.42
Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol (1993) 1.36
Retracted Differential regulation of protein kinase C and (Na,K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells. J Clin Invest (1989) 1.36
Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes (1995) 1.35
Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem (1991) 1.34
Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med (Berl) (1998) 1.28
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest (1995) 1.24
Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest (1995) 1.24
Vascular dysfunction in diabetes mellitus. Lancet (1997) 1.23
In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest (1998) 1.22
Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci (1996) 1.21
Receptor-mediated vectorial transcytosis of epidermal growth factor by Madin-Darby canine kidney cells. J Cell Biol (1987) 1.20
Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display. FASEB J (1994) 1.20
Regulation of insulin receptor internalization in vascular endothelial cells by insulin and phorbol ester. J Biol Chem (1987) 1.18
Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes (2000) 1.13
Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. J Biol Chem (1993) 1.12
Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol (1994) 1.11
Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes (1999) 1.10
Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci (1994) 1.10
Characterization of a common high-affinity receptor for reovirus serotypes 1 and 3 on endothelial cells. J Virol (1989) 1.08
Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol (1995) 1.06
Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci (1996) 1.06
Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol (1989) 1.05
Evaluating retinal circulation using video fluorescein angiography in control and diabetic rats. Curr Eye Res (1992) 1.04
Regulation of receptor-mediated endocytosis by phorbol esters. Biochem Pharmacol (1991) 1.03
Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes (1989) 1.03
Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes (1996) 1.02
Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci (1996) 1.02
Non-parallel evolution of metabolic and growth-promoting functions of insulin. Nature (1981) 1.02
Retracted Endothelin stimulates a sustained 1,2-diacylglycerol increase and protein kinase C activation in bovine aortic smooth muscle cells. Biochem Biophys Res Commun (1989) 1.01
Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci U S A (1994) 1.01
Protein kinase C activation and its pharmacological inhibition in vascular disease. Vasc Med (2000) 1.00
Interactions between the receptors for insulin and the insulin-like growth factors on adipocytes. J Biol Chem (1982) 1.00
Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes (1994) 1.00
Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. J Clin Invest (1983) 1.00
Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia. Invest Ophthalmol Vis Sci (1996) 0.98
Processing of insulin by bovine endothelial cells in culture. Internalization without degradation. Diabetes (1984) 0.98
Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: relation to human somatomedins and insulin. J Supramol Struct Cell Biochem (1981) 0.98
Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg (2001) 0.97
Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail Monit (2001) 0.97
A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth. Diabetes (1998) 0.96
Reduction of inhibition by a benzodiazepine antagonist, Ro15-1788, in the rat hippocampal slice. Neuroscience (1985) 0.96
Protein kinase C and myocardial biology and function. Circ Res (2000) 0.95
Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes (1998) 0.95
The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats. Invest Ophthalmol Vis Sci (1995) 0.94
Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. Invest Ophthalmol Vis Sci (1997) 0.93
Can VEGF reverse diabetic neuropathy in human subjects? J Clin Invest (2001) 0.92
Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retinal pericytes. Diabetes (1992) 0.92
Intracellular pathways of insulin transport across vascular endothelial cells. Am J Physiol (1988) 0.91
Effects of solar particle event proton radiation on parameters related to ferret emesis. Radiat Res (2013) 0.91
Characterization and partial purification of an endothelial cell growth factor from human platelets. J Clin Invest (1984) 0.90
Synthesis and characterization of molecular hybrids of insulin and insulin-like growth factor I. The role of the A-chain extension peptide. J Biol Chem (1982) 0.90
Surgical and pharmacological dissociation of cardiovascular and emetic responses to intragastric CuSO4. Am J Physiol (1992) 0.89
Modulation of the insulin growth factor II/mannose 6-phosphate receptor in microvascular endothelial cells by phorbol ester via protein kinase C. J Biol Chem (1990) 0.89
Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications? Diabetes Res Clin Pract (1999) 0.89
d-Alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. Diabetes Res Clin Pract (1999) 0.89
Identification of persistent defects in insulin receptor structure and function capillary endothelial cells from diabetic rats. J Clin Invest (1989) 0.87
Demonstration of receptors for insulin and insulin-like growth factors on Swarm rat chondrosarcoma chondrocytes. Evidence that insulin stimulates proteoglycan synthesis through the insulin receptor. J Biol Chem (1982) 0.87
Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues. Endocrinology (1985) 0.87
Endothelin stimulates a sustained 1,2-diacylglycerol increase and protein kinase C activation in bovine aortic smooth muscle cells. Biochem Biophys Res Commun (1991) 0.87
Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J Am Soc Nephrol (1997) 0.87
Receptors for and effects of insulin and IGF-I in rat glomerular mesangial cells. Am J Physiol (1988) 0.86
von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care (2000) 0.86
The human erythrocyte insulin-like growth factor I receptor: characterization and demonstration of ligand-stimulated autophosphorylation. J Clin Endocrinol Metab (1986) 0.86
Overexpression of core 2 N-acetylglycosaminyltransferase enhances cytokine actions and induces hypertrophic myocardium in transgenic mice. FASEB J (1999) 0.85
Retracted Characterization of endothelin receptors and effects of endothelin on diacylglycerol and protein kinase C in retinal capillary pericytes. Diabetes (1989) 0.84
Processing and release of insulin and insulin-like growth factor I by macro- and microvascular endothelial cells. Endocrinology (1986) 0.84
Role of protein kinase C in glucose- and angiotensin II-induced plasminogen activator inhibitor expression. Contrib Nephrol (1996) 0.84
Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an alpha-glucosidase inhibitor. Curr Eye Res (1995) 0.83
Vitamin E normalizes diacylglycerol-protein kinase C activation induced by hyperglycemia in rat vascular tissues. Diabetes (1996) 0.83
Regulation by metformin of the hexose transport system in vascular endothelial and smooth muscle cells. Br J Pharmacol (1996) 0.82
Autoantibodies to insulin receptors in man: immunological determinants and mechanism of action. Ciba Found Symp (1982) 0.82
Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest (1995) 0.82